Electrochemical and Plasmonic Detection of Myocardial Infarction Using Microfluidic Biochip Incorporated with Mesoporous Nanoscaffolds
ACS Applied Materials & Interfaces · 2024
DOI: 10.1021/acsami.4c01398 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2024. Verfasst von Nawab Singh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrical and Computer Engineering, Iowa State University, Ames, Iowa 50011, United States. Hauptthemen laut MEDLINE: Myocardial Infarction, Troponin I, Graphite, Electrochemical Techniques. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: Agricultural Research Service, Indian Institute of Technology Hyderabad.
Abstract (Originalsprache)
This paper reports a microfluidic device for the electrochemical and plasmonic detection of cardiac myoglobin (cMb) and cardiac troponin I (cTnI) with noticeable limits of detection (LoD) as low as a few picograms per milliliter (pg/mL) ranges, achieved in a short detection time. The device features two working electrodes, each with a mesoporous Ni3V2O8 nanoscaffold grafted with reduced graphene oxide (rGO) that improves the interaction of diffusing analyte molecules with the sensing surface by providing a high surface area and reaction kinetics. Electrochemical studies reveal sensitivities as high as 9.68 μA ng/mL and a LoD of 2.0 pg/mL for cTnI, and 8.98 μA ng/mL and 4.7 pg/mL for cMb. Additionally, the surface plasmon resonance (SPR) studies demonstrate a low-level LoD of 8.8 pg/mL for cMb and 7.3 pg/mL for cTnI. The dual-modality sensor enables dynamic tracking of kinetic antigen-antibody interactions during sensing, self-verification through providing signals of two modes, and reduced false readout. This study demonstrates the complementary nature of the electrochemical and SPR modes in biosensing, with the electrochemical mode being highly sensitive and the SPR mode providing superior tracking of molecular recognition behaviors. The presented sensor represents a significant innovation in cardiovascular disease management and can be applied to monitor other clinically important biomolecules.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Electrical and Computer Engineering, Iowa State University, Ames, Iowa 50011, United States.
- Department of Biomedical Engineering, Indian Institute of Technology Hyderabad, Hyderabad 502284, India.
- Department of Environmental Engineering, Florida Polytechnic University, Lakeland, Florida 33805, United States.
- Department of Chemical Engineering, Indian Institute of Technology Kanpur, Kanpur 208016, India.
- Microelectronics Research Center, Iowa State University, Ames, Iowa 50011, United States.
- Environment & Biomedical Metrology Section, CSIR-National Physical Laboratory, New Delhi 110012, India.
ORCID-Profile: Ajeet Kaushik, Liang Dong, Ashutosh Sharma, Bansi D Malhotra, Renu John
Förderung
- Agricultural Research Service
- Indian Institute of Technology Hyderabad
Zitieren
APA
Singh, N., Kaushik, A., Ghori, I., Rai, P., Dong, L., Sharma, A., Malhotra, B. D., & John, R. (2024). Electrochemical and Plasmonic Detection of Myocardial Infarction Using Microfluidic Biochip Incorporated with Mesoporous Nanoscaffolds. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c01398
Vancouver
Singh N, Kaushik A, Ghori I, Rai P, Dong L, Sharma A, et al. Electrochemical and Plasmonic Detection of Myocardial Infarction Using Microfluidic Biochip Incorporated with Mesoporous Nanoscaffolds. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c01398
BibTeX
@article{Singh2024,
author = {Singh, Nawab and Kaushik, Ajeet and Ghori, Inayathullah and Rai, Prabhakar and Dong, Liang and Sharma, Ashutosh and Malhotra, Bansi D and John, Renu},
title = {Electrochemical and Plasmonic Detection of Myocardial Infarction Using Microfluidic Biochip Incorporated with Mesoporous Nanoscaffolds},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
doi = {10.1021/acsami.4c01398}
}
EUVIMED